Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: J Heart Lung Transplant. 2019 Nov 26;39(5):441–453. doi: 10.1016/j.healun.2019.11.016

Table 5.

Estimated survival based on blood pressure group in patients on axial flow LVAD support. Patient average blood pressure was calculated from measures obtained month 3 and onward after LVAD.

Estimated Survival (%) during Axial Flow LVAD support
90 day 1 Year 3 Year p* P*
MAP Group, mmHg Log rank p <0.0001
 MAP ≤75 (n at risk) 98.1 ± 0.4% (n=1176) 84 ± 1.1% (n=1173) 57 ± 1.9% (n=731) Reference 0.005
 MAP 76-90 (n at risk) 99.7 ± 0.01% (n=3896) 92 ± 0.5% (n=3867) 70± 1.0% (n=2896) <0.0001 0.004
 MAP 91-100 (n at risk) 99.8 ± 0.1% (n=1496) 93 ± 0.7% (n=1488) 71 ± 1.6% (n=1086) <0.0001 0.005
 MAP >100 (n at risk) 99.4 ± 0.4% (n=478) 89 ± 1.5% (n=470) 62 ± 3.2% (n=329) 0.005 Reference
Doppler Group, mmHg Log rank p <0.0001
 Doppler ≤80 (n at risk) 99.3 ± 0.2% (n=2051) 88 ± 0.8% (n=2023) 61± 1.5% (n=1293) Reference NS
 Doppler 81-95 (n at risk) 99.8± 0.1% (n=4784) 94± 0.4% (n=4762) 74± 0.8% (n=3651) <0.0001 0.001
 Doppler 96-105 (n at risk) 99.9± 0.1% (n=1212) 94± 0.7% (n=1209) 74± 1.7% (n=899) <0.0001 NS
 Doppler >105 (n at risk) 99.8 ± 0.2% (n=572) 92± 1.2% (n=571) 66± 2.8% (n=399) NS Reference
SBP Group, mmHg Log rank p<0.0001
 SBP <90 (n at risk) 98.9 ± 0.2% (n=2150) 85 ± 0.8% (n=2105) 58 ± 1.4% (n=1308) Reference 0.001
 SBP 90-107 (n at risk) 99.6 ± 0.1% (n=3969) 92 ± 0.4% (n=3935) 70 ± 1.0% (n=2897) <0.0001 NS
 SBP 108-119 (n at risk) 99.9 ± 0.1% (n=1722) 92 ± 0.7% (n=1717) 70 ±1.5% (n=1261) <0.0001 NS
 SBP ≥120 (n at risk) 99.6 ± 0.2% (n=857) 90 ±1.2% (n=724) 65 ± 2.5% (n=491) 0.001 Reference

NS= nonsignificant after Bonferroni adjustment (*p threshold p≤0.006)